Gedeon Richter Plc. (RGEDF)
OTC
Closed
Aug 21, 2026
Day's Range
41.8152 wk Range
27.17Overview - RGEDF - Gedeon Richter Plc.
Key Statistics
Valuation
Enterprise Value
-178.10B
P/E (Trailing)
‪11.06‬
PEG Ratio
‪-2.57‬
Price / Sales (TTM)
‪0.0082‬
Price / Book
‪0.0057‬
EV / EBITDA
‪-0.50‬
Profitability
Profit Margin
‪23.34%‬
Operating Margin
‪31.78%‬
Return on Assets
‪11.57%‬
Return on Equity
‪16.19%‬
Ownership
Shares Outstanding
182.39M
Float
182.39M
Held by Insiders
‪25.24%‬
Held by Institutions
‪35.93%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪39.23‬
200-Day Avg
‪35.30‬
Dividends
Payout Ratio
‪55.50%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RGEDF - Gedeon Richter Plc.
Peers - RGEDF - Gedeon Richter Plc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - RGEDF - Gedeon Richter Plc.
About
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest, Hungary, founded in 1901 by pharmacist Gedeon Richter. As the largest pharmaceutical firm in Central and Eastern Europe, it employs approximately 13,000 people worldwide and maintains operations in over…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
